Clinical Trial Update: Predictive Factors for the Efficacy of CD19 CAR-T Therapy in Relapsed/Refractory Large B-Cell Lymphoma: A Clinical Study

View source ↗

Summary

This clinical trial update reports ongoing recruitment for a study aimed at identifying predictive factors for the efficacy of CD19 CAR-T therapy in relapsed/re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• CD19 CAR-T therapy (CD19-targeted CAR-T cell therapy)

Snippet

Sponsor: Fudan University | Conditions: Large B-Cell Lymphoma | Status: RECRUITING